Notice of Intent to Reissue PAR-18-845 “Electronic Nicotine Delivery Systems (ENDS): Basic Mechanisms of Health Effects (R01 - Clinical Trial Not Allowed)” and PAR-18-846 (R21 - Clinical Trial Not Allowed) as a Notice of Special Interest (NOSI)
Notice Number:
NOT-OD-21-113

Key Dates

Release Date:

April 23, 2021

Related Announcements

PAR-18-845 - Electronic Nicotine Delivery Systems (ENDS): Basic Mechanisms of Health Effects (R01 - Clinical Trial Not Allowed)

PAR-18-846 - Electronic Nicotine Delivery Systems (ENDS): Basic Mechanisms of Health Effects (R21 - Clinical Trial Not Allowed)

Issued by

Division of Program Coordination, Planning and Strategic Initiatives, Office of Disease Prevention (ODP)

National Institute of Dental and Craniofacial Research (NIDCR)

National Institute on Drug Abuse (NIDA)

National Institute of Environmental Health Sciences (NIEHS)

National Cancer Institute (NCI)

Purpose

This Notice is to inform the research community that the Office of Disease Prevention and participating NIH Institutes, Centers, and Offices intend to reissue the Funding Opportunity Announcement (FOA) PAR-18-845 "Electronic Nicotine Delivery Systems (ENDS): Basic Mechanisms of Health Effects (R01 - Clinical Trial Not Allowed)" and PAR-18-846  “Electronic Nicotine Delivery Systems (ENDS): Basic Mechanisms of Health Effects (R21 - Clinical Trial Not Allowed)."

When reissued, these FOAs will utilize the Notice of Special Interest (NOSI) mechanism. Modifications to this FOA will be the inclusion of new and revised research priorities. This Notice is being published now to inform prospective applicants in advance of this action. The NOSI is expected to be published in June 2021.

Research Initiative

The purpose of the forthcoming NOSI is to communicate our interest in research examining how electronic nicotine delivery systems (ENDS) affect normal and disease states relevant to human cells, tissues, and organs. Research on alternative nicotine and tobacco delivery systems [e.g., heated tobacco products (also called heat-not-burn)] will also be considered. Studies exclusively examining smokeless tobacco or combustible tobacco products (e.g., cigarettes, cigars) will be considered non-responsive.

Inquiries

Please direct all inquiries to:

Melissa C. Green Parker, PhD
Office of Disease Prevention (ODP)
Telephone: 301-480-1161
Email: melissa.greenparker@nih.gov


Weekly TOC for this Announcement
NIH Funding Opportunities and Notices